Charles River and Related Sciences Enter Multi-Program Collaboration to Pursue AI-Enabled Drug Discovery Utilizing LogicaBusiness Wire • 09/14/23
Steer Clear of Outrageously Valued VinFast Stock. 3 EV Stocks to Buy Instead.InvestorPlace • 09/06/23
Charles River and PathoQuest Announce Publication of a Head-to-Head Study Validating Proprietary Next Generation Sequencing Viral Safety Assay as a Reliable In Vitro Alternative to Animal Testing MethodsBusiness Wire • 09/06/23
Thailand's Government Pension Fund Selects Charles River for Managing Their Front Office OperationsBusiness Wire • 08/30/23
Charles River Lab signs joint agreement for protection of crabs used in medical testsReuters • 08/24/23
Charles River Laboratories Announces Plasmid Manufacturing Collaboration with Fondazione TelethonBusiness Wire • 08/24/23
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Charles River Laboratories International, Inc. (NYSE: CRL)PRNewsWire • 08/22/23
Charles River Laboratories (CRL) Beats Q2 Earnings and Revenue EstimatesZacks Investment Research • 08/09/23
Charles River Laboratories Expands Access to AAALAC-Accredited, Turnkey Research Space in Key MarketsBusiness Wire • 08/01/23
Rathbone Funds Now Live on Charles River IMS® and State Street Alpha® Data PlatformBusiness Wire • 07/20/23
Charles River Laboratories Schedules Second-Quarter 2023 Earnings Release and Conference CallBusiness Wire • 07/19/23
CRL ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 18, 2023 in the Class Action Filed on Behalf of Charles River Laboratories International, Inc. ShareholdersPRNewsWire • 07/18/23
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charles River Laboratories International, Inc. - CRLPRNewsWire • 07/17/23
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Charles River Laboratories International, Inc. (CRL)Business Wire • 07/17/23